Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Sold by Barclays PLC
Barclays PLC cut its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 8.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,972 shares of the biotechnology company’s stock after selling 3,484 shares during the period. […]
Barclays PLC cut its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 8.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,972 shares of the biotechnology company’s stock after selling 3,484 shares during the period. […]
